The classic website will no longer be available as of June 25, 2024. Please use the modernized

Key Record Dates Identifier: NCT05259917
Brief Title: A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

First Submitted : February 4, 2022
First Submitted that Met QC Criteria : February 28, 2022
First Posted : March 2, 2022

Last Update Submitted that Met QC Criteria : January 30, 2024
Last Update Posted : January 31, 2024